Found: 1
Select item for more details and to access through your institution.
Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 464, p. 1, doi. 10.1126/scitranslmed.aat0150
- By:
- Publication type:
- Article